alkenes has been researched along with arginine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, T; Esaka, A; Fujii, N; Nakashima, H; Oishi, S; Otaka, A; Peiper, SC; Tamamura, H; Trent, JO; Ueda, S; Wang, Z; Yamamoto, N | 1 |
| Fehrentz, JA; Martinez, J; Moulin, A | 1 |
| Contreras, R; Frangos, JA; Gramaglia, I; Intaglietta, M; Meays, D; Nolan, JP; Sobolewski, P; van der Heyde, HC | 1 |
| Rahmati, A; Vakili, K | 1 |
| Frosina, G; Rossi, O | 1 |
| Darzynkiewicz, Z; Del Bino, G; Hotz, MA; Lassota, P; Traganos, F | 1 |
| Anderson, H; Harder, KW; Hung, SM; Jirik, FR; Roberge, M; Tudan, C | 1 |
| de Jong, RS; de Vries, EG; Groen, HJ; Höppener, FJ; Mulder, NH; Sleijfer, DT; Uges, DR; van der Graaf, WT; Willemse, PH | 1 |
1 review(s) available for alkenes and arginine
| Article | Year |
|---|---|
Synthesis of peptide aldehydes.
Topics: Aldehydes; Alkenes; Amino Acid Sequence; Arginine; Aspartic Acid; Models, Chemical; Molecular Structure; Peptides; Stereoisomerism | 2007 |
1 trial(s) available for alkenes and arginine
| Article | Year |
|---|---|
Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.
Topics: Adult; Aged; Alanine Transaminase; Alkenes; Antibiotics, Antineoplastic; Aspartate Aminotransferases; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Half-Life; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Polyenes; Pyrones; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1999 |
6 other study(ies) available for alkenes and arginine
| Article | Year |
|---|---|
Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds.
Topics: Alkenes; Animals; Arginine; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Models, Molecular; Molecular Mimicry; Oligopeptides; Peptides, Cyclic; Radioligand Assay; Receptors, CXCR4; Stereoisomerism; Structure-Activity Relationship; Sulfides | 2005 |
Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria.
Topics: Alkenes; Animals; Arginine; Blood Pressure; Capillary Permeability; Cyclic GMP; Hemoglobins; Malaria, Cerebral; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Animal; Models, Biological; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Plasmodium berghei; Tissue Distribution | 2006 |
L-Histidine and L-arginine promote Knoevenagel reaction in water.
Topics: Aldehydes; Alkenes; Arginine; Chemical Phenomena; Histidine; Models, Chemical; Water | 2010 |
Effect of topoisomerase poisoning by antitumor drugs VM 26, fostriecin and camptothecin on DNA repair replication by mammalian cell extracts.
Topics: Alkenes; Animals; Antibiotics, Antineoplastic; Camptothecin; Cell Extracts; Cricetinae; DNA Repair; DNA Replication; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; In Vitro Techniques; Polyenes; Pyrones; Teniposide | 1992 |
Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells.
Topics: Alkenes; Amsacrine; Antibiotics, Antineoplastic; Cell Cycle; DNA, Neoplasm; Humans; Leukemia, Lymphoid; Leukemia, Promyelocytic, Acute; Polyenes; Pyrones; Teniposide; Tumor Cells, Cultured | 1992 |
Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A.
Topics: Alkenes; Animals; Antibiotics, Antineoplastic; Camptothecin; CDC2 Protein Kinase; Cells, Cultured; Cricetinae; DNA Damage; DNA Replication; G2 Phase; Mitosis; Phosphoprotein Phosphatases; Polyenes; Protein Phosphatase 1; Protein Phosphatase 2; Pyrones; Teniposide | 1994 |